Convalescent Plasma
/ Post Graduate Institute of Medical Education and Research
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
January 06, 2022
Comparative Safety and Efficacy of Remdesivir Versus Remdesivir Plus Convalescent Plasma Therapy (CPT) and the Effect of Timing of Initiation of Remdesivir in COVID-19 Patients: An Observational Study From North East India.
(PubMed, Cureus)
- "Conclusions Early initiation of remdesivir was associated with clinical benefit in terms of mortality and mechanical ventilation requirement. However, addition of convalescent plasma therapy as an additional therapeutic modality to remdesivir was not found to be beneficial."
Clinical • Journal • Observational data • Infectious Disease • Novel Coronavirus Disease
October 21, 2021
[VIRTUAL] PROFILE OF SARS CoV2 INFECTION AMONG LIVER TRANSPLANT RECIPIENTS ACROSS ASIA PACIFIC
(AASLD 2021)
- P=N/A | "Any antiviral was received by 36%, convalescent plasma by 26% and immunomodulators like tocilizumab or bevacizumab in 13%. Compared to general population post-LT patients have an increased mortality due to COVID . Home based care could be feasible in only half of the patients ."
Clinical • Diabetes • Genetic Disorders • Hepatology • Hypertension • Immune Modulation • Infectious Disease • Inflammation • Liver Failure • Metabolic Disorders • Non-alcoholic Steatohepatitis • Novel Coronavirus Disease • Obesity • Pulmonary Disease • Respiratory Diseases • Transplantation
October 06, 2021
Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial.
(PubMed, BMJ Open)
- "In this cohort of moderately and severely ill patients with COVID-19, severity of illness, underlying comorbidities and elevated levels of inflammatory markers were significantly associated with death."
Clinical • Journal • Critical care • Infectious Disease • Novel Coronavirus Disease • IL6
May 21, 2021
International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses.
(PubMed, Vox Sang)
- No abstract available
Journal • Infectious Disease • Novel Coronavirus Disease
April 09, 2020
Newly added product
(India Today)
- Preclinical, Novel coronavirus disease
Pipeline update
1 to 5
Of
5
Go to page
1